GLP-1 Education Hub

← Back to Services

GLP-1 medications represent one of the most significant advances in metabolic health in decades. At Foraker Wellness, we provide clear, honest guidance to help you understand your options.

How GLP-1 Medications Work

• Reduce hunger and appetite signals
• Improve feelings of fullness (satiety)
• Slow gastric emptying
• Support insulin regulation and blood sugar stability

Why They Help Sleep Apnea

Zepbound (tirzepatide) is the first GLP-1 medication FDA-approved specifically for obstructive sleep apnea — making it a uniquely relevant therapy for our patient population.

Medications We Use

• Zepbound — FDA-approved for OSA and chronic weight management
• Mounjaro — tirzepatide, approved for type 2 diabetes
• Ozempic — semaglutide, approved for type 2 diabetes
• Wegovy — semaglutide, approved for chronic weight management
• Compounded semaglutide or tirzepatide — when appropriate and legally compliant

Frequently Asked Questions

What are the differences between these medications?

Zepbound and Mounjaro contain tirzepatide (targets two receptors: GIP and GLP-1). Ozempic and Wegovy contain semaglutide (targets one receptor). Both are highly effective; the right choice depends on your health profile, insurance, and goals.

How long does treatment last?

GLP-1 therapy is typically long-term. Most patients do best staying on medication to maintain results, though we'll work with you to find the right approach.

What results can I expect?

Clinical trials show average weight loss of 15-22% of body weight over 12-18 months with tirzepatide. Individual results vary based on adherence, lifestyle, and starting weight.

Do I need labs before starting?

Yes — we conduct a comprehensive metabolic evaluation before starting any GLP-1 therapy to ensure it's safe and appropriate for you.